Gene · 3913
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the interaction between extracellular matrix components in a 3D organoid disease model to replicate the pathophysiology of breast cancer. | J Exp Clin Cancer Res | 2023 | 38102637 | PubTator, text mining | PubMed |
| An in vitro model of cancer invasion with heterogeneous ECM created with droplet microfluidics. | Front Bioeng Biotechnol | 2023 | 38076430 | PubTator, text mining | PubMed |
| Asteroid impact: the potential of astrocytes to modulate human neural networks within organoids. | Front Neurosci | 2023 | 38075269 | PubTator, text mining | PubMed |
| Recombinant Laminin-511 Fragment (iMatrix-511) Coating Supports Maintenance of Human Nucleus Pulposus Progenitor Cells In Vitro. | Int J Mol Sci | 2023 | 38069038 | PubTator, text mining | PubMed |
| Epigenetic and Genetic Keys to Fight HPV-Related Cancers. | Cancers (Basel) | 2023 | 38067286 | PubTator, text mining | PubMed |
| Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles. | Acta Neuropathol Commun | 2023 | 38066589 | PubTator, text mining | PubMed |
| The senescent mesothelial matrix accentuates colonization by ovarian cancer cells. | Cell Mol Life Sci | 2023 | 38043093 | PubTator, text mining | PubMed |
| Cancer stem cells and their niche in cancer progression and therapy. | Cancer Cell Int | 2023 | 38041196 | PubTator, text mining | PubMed |
| The cross-talk between macrophages and tumor cells as a target for cancer treatment. | Front Oncol | 2023 | 38033495 | PubTator, text mining | PubMed |
| Extracellular matrix analysis of fibrosis: A step towards tissue engineering for urethral stricture disease. | PLoS One | 2023 | 38032942 | PubTator, text mining | PubMed |
| Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling. | J Exp Clin Cancer Res | 2023 | 38031171 | PubTator, text mining | PubMed |
| Decellularized diseased tissues: current state-of-the-art and future directions. | MedComm (2020) | 2023 | 38020712 | PubTator, text mining | PubMed |
| Disclosing the molecular profile of the human amniotic mesenchymal stromal cell secretome by filter-aided sample preparation proteomic characterization. | Stem Cell Res Ther | 2023 | 38012707 | PubTator, text mining | PubMed |
| Papain-Based Solubilization of Decellularized Extracellular Matrix for the Preparation of Bioactive, Thermosensitive Pregels. | Biomacromolecules | 2023 | 38009757 | PubTator, text mining | PubMed |
| Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma. | J Pers Med | 2023 | 38003931 | PubTator, text mining | PubMed |
| Whole Genome Expression Profiling of Semitendinosus Tendons from Children with Diplegic and Tetraplegic Cerebral Palsy. | Biomedicines | 2023 | 38001919 | PubTator, text mining | PubMed |
| Nidogen-1/NID1 Function and Regulation during Progression and Metastasis of Colorectal Cancer. | Cancers (Basel) | 2023 | 38001576 | PubTator, text mining | PubMed |
| Detecting host responses to microbial stimulation using primary epithelial organoids. | Gut Microbes | 2023 | 37992398 | PubTator, text mining | PubMed |
| Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer. | NPJ Precis Oncol | 2023 | 37990050 | PubTator, text mining | PubMed |
| Characterization of Expression and Function of the Formins FHOD1, INF2, and DAAM1 in HER2-Positive Breast Cancer. | J Breast Cancer | 2023 | 37985384 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/papers?page=12